| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702761 | Urologic Oncology: Seminars and Original Investigations | 2017 | 6 Pages |
Abstract
Beta-blocker use for hypertension within 90 days before surgery was not associated with the risk of progression, death from RCC, or death from any cause.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
William P. M.D., Christine M. M.S., Harras B. M.D., John C. M.D., Stephen A. M.D., Bradley C. M.D., R. Houston M.D.,